ImmunoPhotonics
Columbia
About ImmunoPhotonics
ImmunoPhotonics develops immunotherapy-based treatments for cancer. A minimally invasive therapeutic cancer vaccine for the treatment of metastatic solid tumors. ImmunoPhotonics has a strategic partnership with Veterinary Cancer Therapeutics, LLC. The company was founded in 2008 and is based in Columbia, Missouri.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $31.9M
- Last round: Series Unknown (Mar 2024)
- Website: immunophotonics.com
- Phone: 636-675-6161
Industries & Categories
Biotechnology, Health Care, Life Science
Social Profiles
Canonical: https://fsome.com/organization/immunophotonics-82515 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.